Skip to Content
Merck
CN

742503

Calcium silicate

purum, 12-22% Ca (as CaO) basis, ≥87% SiO2 basis

Synonym(s):

Calcium hydrosilicate, Calcium monosilicate, Calcium polysilicate, Calsilite, Silicic acid, calcium salt

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

CAS Number:
1344-95-2
NACRES:
NA.22
PubChem Substance ID:
329765578
UNSPSC Code:
12352301
EC Number:
215-710-8
MDL number:
MFCD00015979
Assay:
≥87% SiO2 basis
Form:
solid

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Calcium silicate, purum, 12-22% Ca (as CaO) basis, ≥87% SiO2 basis

InChI key

OYACROKNLOSFPA-UHFFFAOYSA-N

InChI

1S/Ca.O3Si/c;1-4(2)3/q+2;-2

SMILES string

[Ca++].[O-][Si]([O-])=O

grade

purum

assay

≥87% SiO2 basis

form

solid

composition

Ca (as CaO), 12-22% T

loss

≤7.0% loss on drying, 2h; 105°C

particle size

7.0-10.0 μm

pH

9.5-11.5 (5% in H2O)

density

2.9 g/mL at 25 °C (lit.)

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

Calcium silicate can be used as a precursor to synthesize several biomaterials. Examples for such applications include the preparation of biocompatible nanocomposites for bone tissue regeneration and the synthesis of sol-gel hybrid bioactive glasses.

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCN6788
BCCM4898
BCCK7763
BCCJ9014
BCCJ5924

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Utilizing bioactive liners. Stimulating post-traumatic dentin formation.
Jack D Griffin
Dentistry today, 31(10), 132-132 (2012-11-20)
Chen Wang et al.
Biomaterials, 34(1), 64-77 (2012-10-17)
As a potential bioactive material, β-calcium silicate (β-CS) has attracted particular attention in the field of bone regeneration. In this study, porous β-CS/Poly-D,L-Lactide-Glycolide (PDLGA) composite scaffolds were developed with the goals of controlling the degradation rate and improving the mechanical
Li Yuan et al.
Langmuir : the ACS journal of surfaces and colloids, 29(2), 734-743 (2012-12-21)
A novel controlled drug-delivery system (CDDS) based on fluorescent mesoporous silica nanoparticles (FMSN) covalently linked with paclitaxel (PTX) via a disulfide linker was designed and characterized. A PTX prodrug based on a disulfide linker was synthesized, and its drug-delivery mechanism
Han Guo et al.
International journal of nanomedicine, 7, 3613-3624 (2012-08-01)
The purpose of this study was to synthesize a self-setting bioactive cement by incorporation of wollastonite nanofibers (WNFs) into calcium phosphate cement (CPC). The composition, morphology, setting time, compressive strength, hydrophilicity, and degradation of WNF-doped CPC (wnf-CPC) were investigated. Scanning
Hongjie Hu et al.
Colloids and surfaces. B, Biointerfaces, 101, 83-90 (2012-07-17)
To improve the bioactivity and cytocompatibility of biomedical titanium dioxide coating, many efforts have been made to modify its surface composition and topography. Meanwhile, CaSiO(3) was commonly investigated as coating material on titanium implants for fast fixation and firm implant-bone
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service